These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37229927)

  • 1. Multifunctional nanoparticles for the treatment and diagnosis of osteosarcoma.
    Yuan P; Min Y; Zhao Z
    Biomater Adv; 2023 Aug; 151():213466. PubMed ID: 37229927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.
    Zeng WN; Yu QP; Wang D; Liu JL; Yang QJ; Zhou ZK; Zeng YP
    J Nanobiotechnology; 2021 Mar; 19(1):79. PubMed ID: 33740998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in nanoagents delivery system-based phototherapy for osteosarcoma treatment.
    Ji L; Huang J; Yu L; Jin H; Hu X; Sun Y; Yin F; Cai Y
    Int J Pharm; 2024 Nov; 665():124633. PubMed ID: 39187032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydopamine-modified ZIF-8 nanoparticles as a drug carrier for combined chemo-photothermal osteosarcoma therapy.
    Yin X; Ran S; Cheng H; Zhang M; Sun W; Wan Y; Shao C; Zhu Z
    Colloids Surf B Biointerfaces; 2022 Aug; 216():112507. PubMed ID: 35523102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
    Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
    Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional mesoporous silica nanoparticles for pH-response and photothermy enhanced osteosarcoma therapy.
    Shi Q; Lu Y; Zhang G; Yang X; Li R; Zhang G; Guo X; Song J; Ding Q
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112615. PubMed ID: 35759893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment.
    Shanmugavadivu A; Lekhavadhani S; Miranda PJ; Selvamurugan N
    Biomed Mater; 2024 Feb; 19(2):. PubMed ID: 38324905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress of Phototherapy Applications in the Treatment of Bone Cancer.
    Sun J; Xing F; Braun J; Traub F; Rommens PM; Xiang Z; Ritz U
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced nanoscale drug delivery systems for bone cancer therapy.
    Amiryaghoubi N; Fathi M; Barar J; Omidian H; Omidi Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166739. PubMed ID: 37146918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies.
    Yuan Y; Diao S; Ni X; Zhang D; Yi W; Jian C; Hu X; Li D; Yu A; Zhou W; Fan Q
    J Nanobiotechnology; 2022 Jan; 20(1):44. PubMed ID: 35062957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobiotechnological approaches in osteosarcoma therapy: Versatile (nano)platforms for theranostic applications.
    Jiang Y; He K
    Environ Res; 2023 Jul; 229():115939. PubMed ID: 37088317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligent and spatiotemporal drug release based on multifunctional nanoparticle-integrated dissolving microneedle system for synergetic chemo-photothermal therapy to eradicate melanoma.
    Zhao Y; Zhou Y; Yang D; Gao X; Wen T; Fu J; Wen X; Quan G; Pan X; Wu C
    Acta Biomater; 2021 Nov; 135():164-178. PubMed ID: 34530140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms.
    Wang Y; Zhang L; Zhao G; Zhang Y; Zhan F; Chen Z; He T; Cao Y; Hao L; Wang Z; Quan Z; Ou Y
    J Nanobiotechnology; 2022 Feb; 20(1):83. PubMed ID: 35177075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
    Desai SA; Manjappa A; Khulbe P
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and In Vitro Evaluation of Linear PEI-Shelled Heparin/Berberine Nanoparticles in Human Osteosarcoma U-2 OS Cells.
    Hsu HK; Hsu KH; Cheng YM; Suen HY; Peng SF
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30487471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR: An attractive therapeutic target for osteosarcoma?
    Ding L; Congwei L; Bei Q; Tao Y; Ruiguo W; Heze Y; Bo D; Zhihong L
    Oncotarget; 2016 Aug; 7(31):50805-50813. PubMed ID: 27177330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
    Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
    J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy.
    Zhong J; Wen W; Wang J; Zhang M; Jia Y; Ma X; Su YX; Wang Y; Lan X
    Pharm Res; 2023 Jan; 40(1):231-243. PubMed ID: 36380167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.